Blue Lagoon Corp. lists in Iceland with a $116M raise
Blue Lagoon Corp. raised $116M in an oversubscribed IPO on Nasdaq Iceland. It is a flagship geothermal spa supplier, and it now has public-market capital and public-market scrutiny.
For advisors selling Iceland, the practical question is what the money funds. Expect possible expansion, and watch for changes in pricing, packaging and availability. The sources don't give a use-of-proceeds breakdown, so treat any specific expansion plan as unconfirmed.
Two risks remain for client planning. Volcanic activity on the Reykjanes peninsula can disrupt visits, and competition is a factor. Check current booking and cancellation terms before you confirm Blue Lagoon-linked itineraries. Oversubscription does show investors will pay for spa and geothermal travel, which supports the case that demand for these products is durable.
Aman enters longevity living with ATMA, a Djokovic partnership
Aman has launched ATMA, a longevity-residences brand developed with Novak Djokovic. The first project is planned for Brickell, Miami, in 2031. It includes a 120,000 sq ft wellness center, a hotel and residences.
There is no near-term inventory, so this is not something to sell now. It matters as a signal. A top-tier luxury brand is moving into medical and performance-oriented wellness, and other developers are doing the same. BDMS/Capella's $900M Bangkok wellness residential project and The Estate's longevity club pipeline are cited as related moves.
For advisors, the near-term use is client conversation. High-net-worth travelers will increasingly expect hotel brands to offer longevity programming. That points to future referral and commission opportunities, and to a growing market for clinic-style stays today.
Affluent buyers now weigh health infrastructure in home purchases
Sotheby's reports that about 38% of agents in the $10M+ segment see health-centered design influencing purchases. Wellness real estate is projected to pass $1.1T by 2029.
That gives context for the ATMA-style launches. The buyers who might purchase a longevity residence overlap with the clients who book longevity-clinic stays and medical-wellness retreats. Advisors can use the figure to open conversations with affluent clients about residence-linked wellness programs, and can expect these buyers to ask about screening, diagnostics and program length.
Treat the numbers as an agent-sentiment survey and a market projection, not a measure of bookings. The sources describe a demand signal, not a change in supplier terms.
